期刊
PHARMACEUTICS
卷 13, 期 1, 页码 -出版社
MDPI
DOI: 10.3390/pharmaceutics13010091
关键词
squalene; cyclosporin A; bioconjugate; cardiac cell line; cytotoxicity; cellular uptake
资金
- Fondation pour la Recherche Medicale (FRM) [PBR202006012195]
- Fonds de la Recherche Scientifique (FRSFNRS), PDR-THEMA CARDIO [PC02120F]
- Investissements d'Avenir LabEx PALM [ANR10-LABX-0039-PALM]
Cyclosporin A (CsA) is an immunosuppressive molecule evaluated for ischemic heart diseases. A novel nanoformulation, SqCsA NPs, based on squalene and CsA has shown promising cardioprotective effects on cardiac cell lines, paving the way for potential medical applications.
Cyclosporin A (CsA) is a molecule with well-known immunosuppressive properties. As it also acts on the opening of mitochondrial permeability transition pore (mPTP), CsA has been evaluated for ischemic heart diseases (IHD). However, its distribution throughout the body and its physicochemical characteristics strongly limit the use of CsA for intravenous administration. In this context, nanoparticles (NPs) have emerged as an opportunity to circumvent the above-mentioned limitations. We have developed in our laboratory an innovative nanoformulation based on the covalent bond between squalene (Sq) and cyclosporin A to avoid burst release phenomena and increase drug loading. After a thorough characterization of the bioconjugate, we proceeded with a nanoprecipitation in aqueous medium in order to obtain SqCsA NPs of well-defined size. The SqCsA NPs were further characterized using dynamic light scattering (DLS), cryogenic transmission electron microscopy (cryoTEM), and high-performance liquid chromatography (HPLC), and their cytotoxicity was evaluated. As the goal is to employ them for IHD, we evaluated the cardioprotective capacity on two cardiac cell lines. A strong cardioprotective effect was observed on cardiomyoblasts subjected to experimental hypoxia/reoxygenation. Further research is needed in order to understand the mechanisms of action of SqCsA NPs in cells. This new formulation of CsA could pave the way for possible medical application.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据